The Advanced Genomics Collaboration
The Advanced Genomics Collaboration

News & Events

Locating cancer's source
News
Mar 18, 2024
1
 min read
Locating cancer's source
Developing a rapid multi-omic liquid biopsy blood test utilising whole genome sequencing to resolve the difficult diagnosis of cancer of unknown primary origin.
Improving women's health outcomes through genomics
News
Mar 18, 2024
1
 min read
Improving women's health outcomes through genomics
Performing next-generation sequencing to find new solutions for patients with common endometrial-related health problems such as abnormal menstrual bleeding, infertility and pregnancy disorders.
The future of cancer is very personal
News
Dec 12, 2023
10
 min read
The future of cancer is very personal
Precision medicine allows us to develop treatments for a specific disease in one person. But we must ensure all Australians can access these benefits
TAGC sponsors 2023 MDHS Honours Conference
News
Oct 27, 2023
5
 min read
TAGC sponsors 2023 MDHS Honours Conference
TAGC was proud to sponsor the University of Melbourne’s annual MDHS Honours Conference this year, in line with the partnership’s commitment to supporting scholarship and learning opportunities to equip the next generation of researchers with the skills to lead the genomic workforce of the future.
Making advanced genomic testing more accessible for cancer patients
News
Sep 20, 2023
10
 min read
Making advanced genomic testing more accessible for cancer patients
The TAGC team recently received full diagnostic accreditation through the National Association of Testing Authorities (NATA) to perform ‘ctDNA profiling’ analysing tumour DNA collected via liquid biopsy. It’s a crucial step towards making advanced genomics testing more affordable and accessible.
The University of Melbourne and Peter Mac to establish precision cancer care centre
News
Aug 1, 2023
5
 min read
The University of Melbourne and Peter Mac to establish precision cancer care centre
The University of Melbourne and the Peter MacCallum Cancer Centre will establish a new centre to transform how genomics and precision oncology is delivered in Australia.

Increasing genomics innovation and its translation and adoption into the healthcare system to improve patient outcomes.